Re: Phenergan

[Heather Nichols]

AMEN to that! Heather >>> "Lynn Hadaway" <[EMAIL PROTECTED]> 8/10/2006 5:26 PM >>> Hallelujah, this is long overdue!! Lynn At 8:36 PM +0000 8/10/06, [EMAIL PROTECTED] wrote: >New as of today. > >The ISMP Medication Safety Alert, August 10, 2006 - Volume 11 Issue 16. > >The Institute for Safe Medication Practice. > >Action needed to prevent serious tissue injury with IV promethazine. > >"However, due to the frequency of severe, tragic, local injuries after >infiltration or inadvertent intra-arterial injection, ISMP recommends >that the FDA reexamine the product labeling and consider eliminating the >IV route of administration." > >  Reference newspaper article: >http://www.thedailyworld.com/articles/2005/12/07/local_news/02news.txt > >Please email me privately and I will send you the pdf newsletter as an >attachement.  This is pretty good material to stop the use of IV >Phenergan. > > >Timothy Royer, BSN, CRNI >Nurse Manager / Vascular Access / Diagnostic Service >VA Puget Sound Health Care System >Seattle / American Lake Divisions, WA -- Lynn Hadaway, M.Ed., RNC, CRNI Lynn Hadaway Associates, Inc. 126 Main Street, PO Box 10 Milner, GA 30257 http://www.hadawayassociates.com office 770-358-7861 ----------------------------------------------------- Confidentiality Disclaimer This message, including any attachments, is confidential, intended only for the named recipient(s) and may contain information that is privileged or exempt from disclosure under applicable law, including PHI (Protected Health Information) covered under the Health Insurance Portability and Accountability Act (HIPAA) of 1996.  If you are not the intended recipient(s), you are notified that the dissemination, distribution, or copying of this message is strictly prohibited.  If you receive this message in error, or are not the named recipient(s), please notify the sender or contact the University of Louisville Health Care I.S. helpdesk at 502.562.3637 to report an inadvertently received message. -----------------------------------------------------